Current treatment for these patients relies on first-generation TKI imatinib – sold by Novartis as Glivec but also available as a generic – as well as second-generation drugs such as Bosulif ...

Novartis was never seen as playing in the same league as town rival Roche in oncology. Its leukaemia treatment Glivec – with $4.7 billion sales in 2013 the fourth-largest selling cancer drug ...

A case in point is its seven-year battle to obtain a patent for a new version of its anti-cancer drug Glivec in India. The Indian Supreme Court eventually ruled against Novartis in 2013 on the ...

The authors validated the screening method with agents known to be affected by interactions with the tumour microenvironment, such as doxorubicin and imatinib (Gleevec/Glivec; Novartis).

Novartis India on Monday said it is disappointed with the Supreme Court verdict rejecting its patent plea for blockbuster cancer drug Glivec. It will continue to invest in India, but cautiously ...